EXTON, Pa., Oct. 11, 2018 /PRNewswire/ -- West Pharmaceutical
Services, Inc. (NYSE: WST), a global leader in innovative solutions
for injectable drug administration, today announced that it will
release third-quarter 2018 financial results before the market
opens on Thursday, October 25, 2018,
and will follow with a conference call to discuss the results and
business expectations at 9:00 a.m. Eastern
Time. To participate on the call, please dial 877-930-8295
(U.S.) or 253-336-8738 (International). The conference ID is
8341499.
A live broadcast of the conference call will be available at the
Company's website, www.westpharma.com, in the "Investors" section.
Management will refer to a slide presentation during the call,
which will be made available on the day of the call. To view the
presentation, select "Presentations" in the "Investors" section of
the Company's website.
An online archive of the broadcast will be available at the site
three hours after the live call and will be available through
Thursday, November 1, 2018, by
dialing 855-859-2056 (U.S.) or 404-537-3406 (International). The
conference ID is 8341499.
About West
West Pharmaceutical Services, Inc. is a
leading manufacturer of packaging components and delivery systems
for injectable drugs and healthcare products. Working by the side
of its customers from concept to patient, West creates products
that promote the efficiency, reliability and safety of the world's
pharmaceutical drug supply. West is headquartered in Exton, Pennsylvania, and supports its
customers from locations in North and South America, Europe, Asia
and Australia. West's 2017 net
sales of $1.6 billion reflect the
daily use of approximately 112 million of its components and
devices, which are designed to improve the delivery of healthcare
to patients around the world.
All trademarks and registered trademarks used in this release
are the property of West Pharmaceutical Services, Inc. or its
subsidiaries, in the United States
and other jurisdictions, unless otherwise noted.
Investor
Contact:
|
Media
Contact:
|
Quintin
Lai
|
Emily
Denney
|
Vice President,
Investor Relations
|
Vice President,
Global Communications
|
+1-610-594-3318
|
+1-610-594-3035
|
Quintin.Lai@westpharma.com
|
Emily.Denney@westpharma.com
|
View original content to download
multimedia:http://www.prnewswire.com/news-releases/west-to-host-third-quarter-2018-conference-call-300729119.html
SOURCE West Pharmaceutical Services, Inc.